Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Medical Specialties
|TMO||Thermo Fisher Scientific, Inc.||0.98%||628.33||1.0%||$845.71m|
|ISRG||Intuitive Surgical, Inc.||5.16%||340.49||0.8%||$527.81m|
|BDX||Becton, Dickinson & Co.||1.73%||250.39||1.0%||$383.76m|
|BSX||Boston Scientific Corp.||1.72%||41.40||1.0%||$362.00m|
|ALGN||Align Technology, Inc.||4.35%||666.72||6.4%||$339.55m|
|EW||Edwards Lifesciences Corp.||3.22%||115.56||0.4%||$288.80m|
|A||Agilent Technologies, Inc.||1.63%||153.94||1.6%||$259.09m|
|ZBH||Zimmer Biomet Holdings, Inc.||2.33%||128.41||1.7%||$232.19m|
|IDXX||IDEXX Laboratories, Inc.||3.25%||611.43||3.8%||$226.28m|
|PKI||PerkinElmer, Inc. (United States)||2.16%||185.40||2.4%||$173.66m|
Zeltiq (pronounced Zel Ã¢â‚¬Â²teek) Aesthetics, founded in 2005, is a science-based medical device company dedicated to the development of non-invasive procedures for the reduction of unwanted fat tissue. The Zeltiq approach utilizes a patented method called CryolipolysisÃ¢â€žÂ¢ (the use of precisely controlled cooling to remove fat) that is designed to target only fat cells and not harm the skin or other tissue. The Zeltiq device is cleared by the FDA in the Unites States for various applications related to skin cooling during dermatologic treatments.